San Francisco Firm Launches Research Data Platform
Alethios debuts a suite of decentralized tools to streamline clinical trials and participant-reported data collection.
Updated on Oct. 28, 2026 in Remote Work
Live Poll
Do you trust the data collected from remote, decentralized health studies as much as clinical trials?
San Francisco-based Alethios Inc. has launched a decentralized platform designed to automate clinical research tasks such as participant onboarding and data cleaning. The system integrates wearable data and digital biomarkers to assist with complex study requirements.
Why it matters
The platform aims to reduce total study completion time and research expenses by digitizing labor-intensive coordination tasks. By simplifying the trial process, the company seeks to accelerate the pace at which peer-reviewed research is produced.
The Study Planner platform is available for a monthly subscription cost of $100. Recent performance data from a saliva study showed that 127 out of 144 total participants successfully provided usable samples.
The players
Alethios Inc.
A San Francisco-based technology company that specializes in decentralized research data collection tools.
PLT Health Solutions
An organization that partnered with Alethios to offer decentralized clinical trials.
The details
The platform utilizes a no-code system to integrate wearable devices, lab coordination, and automated participant reminders into one workflow. It is capable of supporting intensive protocols, such as 12-week randomized, double-blind, placebo-controlled trials.
Timeline
June 2026: PLT Health Solutions entered a partnership with Alethios.
Past year: Seven platform studies completed participant enrollment in under 24 hours.
October 28, 2026: Publication date of the announcement.
Market Landscape
The platform aligns with the shift toward remote monitoring as defined in the FDA Guidance on Decentralized Clinical Trials. This technology helps companies navigate the transition away from traditional, site-based research models by automating data collection.
Research organizations and institutions can adopt the platform for a monthly fee of $100 to manage their trials. The automation features aim to reduce the administrative burden on study participants and coordinators.
The takeaway
Decentralized platforms are increasingly vital for maintaining participant engagement in multi-week clinical studies. Researchers should consider integrating automated reminders and device syncing to improve sample return rates.
Further reading
Learn more about the evolution of distributed research tools on the Remote Work section.
Source note: This article includes information reported by NutraIngredients.
Live Poll
Do you trust the data collected from remote, decentralized health studies as much as clinical trials?
